Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a condition in which excess fat accumulates in the liver in association with metabolic risk factors. It is commonly linked to obesity, type 2 diabetes, insulin resistance, high cholesterol and high blood pressure. Early identification and appropriate MASLD management are important to reduce the risk of liver inflammation, progressive scarring and other metabolic complications.
MASLD may develop gradually and often does not cause noticeable symptoms during its early stages. Many individuals discover the condition through routine blood investigations or an abdominal ultrasound. Without appropriate monitoring, some patients may develop metabolic dysfunction-associated steatohepatitis (MASH), which can lead to liver fibrosis and, in advanced cases, cirrhosis.
Common risk factors associated with MASLD include:
Effective MASLD management begins with evaluating liver health and identifying associated metabolic conditions. A detailed medical assessment helps determine individual risk factors and the need for further investigations.
Depending on the patient’s medical history and clinical findings, evaluation may include:
These investigations help assess the condition and guide appropriate medical recommendations.
Lifestyle changes are an important part of managing MASLD. The approach focuses on improving metabolic health, reducing excess liver fat and addressing conditions that may contribute to disease progression.
Management guidance may include:
MASLD requires appropriate follow-up to monitor liver health and associated metabolic conditions. Regular medical reviews and investigations may help assess progress and identify signs of disease progression. Medication may be considered for associated conditions or specific liver-related indications based on individual assessment.
MASLD management focuses on comprehensive medical evaluation, metabolic risk assessment and personalised lifestyle guidance. The aim is to support liver health, manage associated conditions and help reduce the risk of long-term complications through appropriate medical care and continued monitoring.